Affimed N.V FCF yield
What is the FCF yield of Affimed N.V?
The FCF yield of Affimed N.V. is -44.16%
What is the definition of FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield of companies in the Health Care sector on NASDAQ compared to Affimed N.V
What does Affimed N.V do?
affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli
Companies with fcf yield similar to Affimed N.V
- Fission 3.0 has FCF yield of -44.47%
- Pacific Bay Minerals has FCF yield of -44.41%
- Neuropathix has FCF yield of -44.32%
- Aurumin has FCF yield of -44.30%
- Banco Santander Chile SA has FCF yield of -44.21%
- Ora Banda Mining has FCF yield of -44.19%
- Affimed N.V has FCF yield of -44.16%
- Atara Biotherapeutics Inc has FCF yield of -44.07%
- Pan Orient has FCF yield of -44.06%
- Sunrun Inc has FCF yield of -44.05%
- Globus Maritime Ltd has FCF yield of -44.03%
- Emcore has FCF yield of -43.99%
- FAX Capital has FCF yield of -43.96%